The efficacy of dorzolamide, a topical carbonic anhydrase inhibitor, in combination with timolol in the treatment of patients with open-angle glaucoma and ocular hypertension
- 30 June 1996
- journal article
- Published by Elsevier in Clinical Therapeutics
- Vol. 18 (3) , 460-465
- https://doi.org/10.1016/s0149-2918(96)80026-9
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- A Double-Masked, Randomized 1-Year Study Comparing Dorzolamide (Trusopt), Timolol, and BetaxololArchives of Ophthalmology (1950), 1995
- Four-Week Safety and Efficacy Study of Dorzolamide, a Novel, Active Topical Carbonic Anhydrase InhibitorArchives of Ophthalmology (1950), 1993
- Dose Response and Duration of Action of Dorzolamide, a Topical Carbonic Anhydrase InhibitorArchives of Ophthalmology (1950), 1992
- New Developments in the Drug Treatment of GlaucomaDrugs, 1991
- MK-507 versus SezolamideOphthalmology, 1991
- Systemic Effects of Medications Used To Treat GlaucomaAnnals of Internal Medicine, 1990